Krystal Biotech Total Non-Operating Income/Expense 2017-2024 | KRYS
Krystal Biotech total non-operating income/expense for the twelve months ending June 30, 2024 was $0.129B, a 919.91% increase year-over-year.
- Krystal Biotech annual total non-operating income/expense for 2023 was $0.123B, a 2248.67% increase from 2022.
- Krystal Biotech annual total non-operating income/expense for 2022 was $0.005B, a 503.17% decline from 2021.
- Krystal Biotech annual total non-operating income/expense for 2021 was $-0.001B, a 255.65% decline from 2020.